GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced the launch of its next generation of breast implants, Perle.
Perle is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ), GCA's industry-leading gel technology (Emunomic Breast Tissue Dynamic Gel), and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record. The new product line provides surgeons and patients with an advanced line of smooth implants that benefit from GCA's more than 40 years in the industry, its long-term focus on patient safety and innovation, and its exceptional record of customer service and support.
Perle is initially being rolled out in European markets, with other markets around the world to follow in the coming months.
Read more at PR Newswire >>